Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor.
about
Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase II trial of ponatinib in ...... ous tyrosine kinase inhibitor.
@en
Phase II trial of ponatinib in ...... ous tyrosine kinase inhibitor.
@nl
type
label
Phase II trial of ponatinib in ...... ous tyrosine kinase inhibitor.
@en
Phase II trial of ponatinib in ...... ous tyrosine kinase inhibitor.
@nl
prefLabel
Phase II trial of ponatinib in ...... ous tyrosine kinase inhibitor.
@en
Phase II trial of ponatinib in ...... ous tyrosine kinase inhibitor.
@nl
P2860
P50
P1433
P1476
Phase II trial of ponatinib in ...... ous tyrosine kinase inhibitor.
@en
P2093
David Sanford
Jeffrey Skinner
P2860
P304
P356
10.3324/HAEMATOL.2015.132845
P577
2015-09-04T00:00:00Z